03 Aug 2022 Actinogen Actinogen Clinical Trials Science Forum webcast recording
03 Aug 2022 Actinogen Actinogen Clinical Trials Science Forum presentation slides
28 Jul 2022 Actinogen Actinogen CEO presentation to Spark Plus Australian Equities Day
27 Jun 2022 FN Arena Australian Broker Call *Extra* Edition – Jun 27, 2022 | Bell Potter initiates coverage on Australian drug developer Actinogen Medical
14 Jun 2022 Actinogen ACW presentation for BIO International Convention meetings
14 Jun 2022 The Market Herald Actinogen Medical (ASX:ACW) announces phase two trial designs for AD & MDD
14 Jun 2022 Biotech Daily Actinogen Medical Plans Xanamem For Alzheimer’s, Depression Phase II Trials
14 Jun 2022 The Sentiment Why one contentious FDA drug approval is good news for Actinogen Medical
14 Jun 2022 IQ Stock Actinogen Announces Phase 2 Trials in Alzheimer’s Disease and Depression
14 Jun 2022 Global Newswire Actinogen Announces Phase 2 Trials in Alzheimer’s Disease and Depression
14 Jun 2022 Yahoo Finance Actinogen Announces Phase 2 Trials in Alzheimer’s Disease and Depression
14 Jun 2022 Biospace Actinogen Announces Phase 2 Trials in Alzheimer’s Disease and Depression
20 May 2022 Actinogen International Clinical Trials Day
13 May 2022 Ticker Insight Biotech Breakthrough: A clinical step for New Alzheimer’s trial
04 May 2022 Actinogen Actinogen trial results & strategic update presentation
04 May 2022 The Market Herald Actinogen (ASX:ACW) prioritises Alzheimers disease and depression trials
04 May 2022 Market Index Actinogen reassesses its priorities: Clinical programs refocus on cognition
02 May 2022 Aged Care Insite Is Xanamem the Alzheimer’s breakthrough we’ve all been waiting for?
28 Apr 2022 Eminetra Australia Positive test results for Alzheimer’s drug Xanamem
28 Apr 2022 TechInvest Actinogen announces positive XanaMIA Part A trial
28 Apr 2022 Aged Care News Millions could benefit after breakthrough Alzheimer’s treatment trial by Aussie biotech
28 Apr 2022 Hospital and Healthcare Positive trial results for Alzheimer’s drug Xanamem
27 Apr 2022 Actinogen XanaMIA Part A Trial positive topline results for Xanamem – Webcast 27 April 2022
27 Apr 2022 Biotech Daily Actinogen XanaMIA Phase 1B Part A Trial Meets Endpoints
27 Apr 2022 The Sentiment New trial results from Actinogen hold promise for Alzheimer’s treatment
27 Apr 2022 The Market Herald Actinogen Medical (ASX:ACW) reports positive XanaMIA Part A trial topline results
27 Apr 2022 Kalkine Media Actinogen gets upbeat results from Xanamem trial for Alzheimer’s treatment
27 Apr 2022 Mirage News Millions worldwide could benefit after breakthrough trial in treatment for Alzheimer’s
27 Apr 2022 Actinogen ACW positive XanaMIA results webcast slide presentation
27 Apr 2022 Australian Associated Press Millions worldwide could benefit after a breakthrough trial in the treatment for Alzheimer’s
27 Apr 2022 news.com.au Millions worldwide could benefit after a breakthrough trial in the treatment for Alzheimer’s
27 Apr 2022 The Australian Millions worldwide could benefit after a breakthrough trial in the treatment for Alzheimer’s
27 Apr 2022 The National Tribune Millions worldwide could benefit after breakthrough trial in treatment for Alzheimer’s
27 Apr 2022 Actinogen Media Release: Millions worldwide could benefit after a breakthrough trial in the treatment for Alzheimer’s by Aussie biotech Actinogen
26 Apr 2022 Clinical Trials Arena Pipeline Moves: Actinogen makes strides in mild cognitive impairment
08 Mar 2022 Actinogen Celebrating International Women’s Day
01 Mar 2022 Actinogen Actinogen CEO presents at Sachs 15th Annual European Life Sciences Conference
28 Feb 2022 Actinogen Raising Awareness on Rare Disease Day
28 February
11 Feb 2022 The Market Herald Actinogen Medical (ASX:ACW) advances Alzheimer’s treatment
09 Feb 2022 The Sentiment Actinogen appoints leading researchers to conduct Phase 2 trials for treatment of Fragile X Syndrome
09 Feb 2022 The Market Herald Actinogen Medical (ASX:ACW) locks in trial manager for FXS phase-two study
09 Feb 2022 Biotech Daily Worldwide To Manage Xanamem Fragile X Trial
26 Jan 2022 Edison Edison Open House Healthcare 2022
10 Jan 2022 Actinogen Actinogen CEO Presents at San Francisco Healthcare Conference
22 Dec 2021 Stockhead Healthcare has been a hot sector. Here are the top ASX biotech stocks in 2021. Best performing ASX biotechs in 2021.
07 Dec 2021 The Market Herald Actinogen Medical (ASX:ACW) partners with Oxford University
07 Dec 2021 Stockhead ASX Health Stocks: Neuren stock price up 100pc on positive Phase 3 results In other ASX health news this morning: Actinogen Medical (ASX:ACW) has announced strategic collaboration with Oxford University researchers A
29 Nov 2021 The Sentiment Better than a sudoku: could this drug be the key to preventing Alzheimer’s?
25 Nov 2021 Actinogen Actinogen Webcast of Strategic Update and Capital Raising Investor Presentation
25 Nov 2021 Actinogen Actinogen Strategic Update & Capital Raising Investor Presentation

Back
to top